Onconova Therapeutics Analysis

Onconova Stock Analysis Notes

The company has price-to-book ratio of 1.43. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Onconova Therapeutics recorded a loss per share of 0.96. The entity last dividend was issued on the 26th of September 2018. The firm had 1:15 split on the 21st of May 2021. Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. Onconova Therapeutics, Inc. was incorporated in 1998 and is headquartered in Newtown, Pennsylvania. Onconova Therapeutic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 14 people. To find out more about Onconova Therapeutics contact Steven MD at 267 759 3680 or learn more at https://www.onconova.com.

Onconova Therapeutics Investment Alerts

Onconova Therapeutics Upcoming and Recent Events

Onconova Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 20.9 M.

Onconova Therapeutics Insider Trading Activities

Onconova Therapeutics Outstanding Bonds

Onconova Therapeutics Predictive Daily Indicators

Stock analysis is the technique used by a trader or investor to examine and evaluate how Onconova Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Onconova shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Onconova Therapeutics. By using and applying Onconova Stock analysis, traders can create a robust methodology for identifying Onconova entry and exit points for their positions.

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

If you are still planning to invest in Onconova Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Onconova Therapeutics' history and understand the potential risks before investing.